{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:40:04Z","timestamp":1771663204443,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Science and Technology Planning Project of Jilin Province","award":["YDZJ202202CXJD009"],"award-info":[{"award-number":["YDZJ202202CXJD009"]}]},{"name":"Science and Technology Planning Project of Jilin Province","award":["20210204031YY"],"award-info":[{"award-number":["20210204031YY"]}]},{"name":"Science and Technology Planning Project of Jilin Province","award":["20210303002SF"],"award-info":[{"award-number":["20210303002SF"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Somatic variants play a crucial role in the occurrence and progression of cancer. However, in the absence of matched normal controls, distinguishing between germline and somatic variants becomes challenging in tumor samples. The existing tumor-only genomic analysis methods either suffer from limited performance or insufficient interpretability due to an excess of features. Therefore, there is an urgent need for an alternative approach that can address these issues and have practical implications. Here, we presented OncoTOP, a computational method for genomic analysis without matched normal samples, which can accurately distinguish somatic mutations from germline variants. Reference sample analysis revealed a 0% false positive rate and 99.7% reproducibility for variant calling. Assessing 2864 tumor samples across 18 cancer types yielded a 99.8% overall positive percent agreement and a 99.9% positive predictive value. OncoTOP can also accurately detect clinically actionable variants and subclonal mutations associated with drug resistance. For the prediction of mutation origins, the positive percent agreement stood at 97.4% for predicting somatic mutations and 95.7% for germline mutations. High consistency of tumor mutational burden (TMB) was observed between the results generated by OncoTOP and tumor-normal paired analysis. In a cohort of 97 lung cancer patients treated with immunotherapy, TMB-high patients had prolonged PFS (P\u2009=\u2009.02), proving the reliability of our approach in estimating TMB to predict therapy response. Furthermore, microsatellite instability status showed a strong concordance (97%) with polymerase chain reaction results, and leukocyte antigens class I subtypes and homozygosity achieved an impressive concordance rate of 99.3% and 99.9% respectively, compared to its tumor-normal paired analysis. Thus, OncoTOP exhibited high reliability in variant calling, mutation origin prediction, and biomarker estimation. Its application will promise substantial advantages for clinical genomic testing.<\/jats:p>","DOI":"10.1093\/bib\/bbae677","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T01:26:57Z","timestamp":1735608417000},"source":"Crossref","is-referenced-by-count":6,"title":["Precise identification of somatic and germline variants in the absence of matched normal samples"],"prefix":"10.1093","volume":"26","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[{"name":"The Medical Oncology Translational Research Laboratory, Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer, Jilin Cancer Hospital , No. 1066, Jinhu Road, Changchun, 130012 ,","place":["China"]}]},{"given":"Lu","family":"Meng","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1773-367X","authenticated-orcid":false,"given":"Hongke","family":"Wang","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Liang","family":"Cui","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Heyu","family":"Sheng","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Peiyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"The Medical Oncology Translational Research Laboratory, Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer, Jilin Cancer Hospital , No. 1066, Jinhu Road, Changchun, 130012 ,","place":["China"]}]},{"given":"Shuo","family":"Hong","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Xinhua","family":"Du","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Shi","family":"Yan","sequence":"additional","affiliation":[{"name":"The Medical Oncology Translational Research Laboratory, Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer, Jilin Cancer Hospital , No. 1066, Jinhu Road, Changchun, 130012 ,","place":["China"]}]},{"given":"Yun","family":"Xing","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Shicheng","family":"Feng","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Huan","family":"Fang","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Jing","family":"Bai","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]},{"name":"College of Future Technology, Peking University , No. 5 Yiheyuan Road, Beijing , 100871,","place":["China"]}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"The Medical Oncology Translational Research Laboratory, Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer, Jilin Cancer Hospital , No. 1066, Jinhu Road, Changchun, 130012 ,","place":["China"]}]},{"given":"Shaowei","family":"Lan","sequence":"additional","affiliation":[{"name":"The Medical Oncology Translational Research Laboratory, Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer, Jilin Cancer Hospital , No. 1066, Jinhu Road, Changchun, 130012 ,","place":["China"]}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Yanfang","family":"Guan","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Xuefeng","family":"Xia","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Xin","family":"Yi","sequence":"additional","affiliation":[{"name":"Geneplus-Beijing Institute , 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206 ,","place":["China"]}]},{"given":"Ying","family":"Cheng","sequence":"additional","affiliation":[{"name":"The Department of Medical Oncology, Jilin Cancer Hospital , No. 1066, Jinhu Road, Changchun, 130012 ,","place":["China"]}]}],"member":"286","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"2024123101253107700_ref1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"The Oslo Breast Cancer Consortium (OSBREAC)","year":"2012","journal-title":"Nature"},{"key":"2024123101253107700_ref2","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1038\/ncomms4156","article-title":"Integrated analysis of germline and somatic variants in ovarian cancer","volume":"5","author":"Kanchi","year":"2014","journal-title":"Nat Commun"},{"key":"2024123101253107700_ref3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"2024123101253107700_ref4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"2024123101253107700_ref5","doi-asserted-by":"crossref","first-page":"e87212","DOI":"10.1371\/journal.pone.0087212","article-title":"Genome-wide identification of somatic aberrations from paired normal-tumor samples","volume":"9","author":"Li","year":"2014","journal-title":"PloS One"},{"key":"2024123101253107700_ref6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/bioinformatics\/btr665","article-title":"SomaticSniper: Identification of somatic point mutations in whole genome sequencing data","volume":"28","author":"Larson","year":"2012","journal-title":"Bioinformatics"},{"key":"2024123101253107700_ref7","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-020-16785-6","article-title":"A user guide for the online exploration and visualization of PCAWG data","volume":"11","author":"Goldman","year":"2020","journal-title":"Nat Commun"},{"key":"2024123101253107700_ref8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Chang","year":"2013","journal-title":"Nat Genet"},{"key":"2024123101253107700_ref9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ccell.2018.04.001","article-title":"Tumor mutational burden and efficacy of Nivolumab monotherapy and in combination with Ipilimumab in small-cell lung cancer","volume":"33","author":"Hellmann","year":"2018","journal-title":"Cancer Cell"},{"key":"2024123101253107700_ref10","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1056\/NEJMoa1613493","article-title":"First-line Nivolumab in stage IV or recurrent non-small-cell lung cancer","volume":"376","author":"Carbone","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"2024123101253107700_ref11","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in Tumors with mismatch-repair deficiency","volume":"372","author":"le","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"2024123101253107700_ref12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.aao4572","article-title":"Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy","volume":"359","author":"Chowell","year":"2018","journal-title":"Science"},{"key":"2024123101253107700_ref13","doi-asserted-by":"crossref","first-page":"e1005965","DOI":"10.1371\/journal.pcbi.1005965","article-title":"A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal","volume":"14","author":"Sun","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"2024123101253107700_ref14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1200\/CCI.19.00130","article-title":"Reliable analysis of clinical tumor-only whole-exome sequencing data","volume":"4","author":"Oh","year":"2020","journal-title":"JCO Clinical Cancer Informatics"},{"key":"2024123101253107700_ref15","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.celrep.2018.10.046","article-title":"Reliability of whole-exome sequencing for assessing Intratumor genetic heterogeneity","volume":"25","author":"Shi","year":"2018","journal-title":"Cell Rep"},{"key":"2024123101253107700_ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-017-0118-2","article-title":"Evaluating somatic tumor mutation detection without matched normal samples","volume":"11","author":"Teer","year":"2017","journal-title":"Hum Genomics"},{"key":"2024123101253107700_ref17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.annonc.2020.01.014","article-title":"Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma","volume":"31","author":"Lin","year":"2020","journal-title":"Ann Oncol"},{"key":"2024123101253107700_ref18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ccr3.2073","article-title":"Clinical characteristics and genetic analysis of gene mutations in a Chinese pedigree with Peutz-Jeghers syndrome","volume":"7","author":"Qiu","year":"2019","journal-title":"Clin Case Rep"},{"key":"2024123101253107700_ref19","doi-asserted-by":"crossref","first-page":"1285296","DOI":"10.3389\/fimmu.2023.1285296","article-title":"Case report: Successful conversion and salvage resection of huge hepatocellular carcinoma with portal vein tumor thrombosis and intrahepatic metastasis via sequential hepatic arterial infusion chemotherapy, lenvatinib plus PD-1 antibody followed by simultaneous transcatheter arterial chemoembolization, and portal vein embolization","volume":"14","author":"Luo","year":"2023","journal-title":"Front Immunol"},{"key":"2024123101253107700_ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: A precision oncology Knowledge Base","volume":"1","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"2024123101253107700_ref21","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0709662105","article-title":"The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP","volume":"105","author":"Yun","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"2024123101253107700_ref22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12920-017-0296-8","article-title":"A method to reduce ancestry related germline false positives in tumor only somatic variant calling","volume":"10","author":"Halperin","year":"2017","journal-title":"BMC Med Genomics"},{"key":"2024123101253107700_ref23","article-title":"UNMASC: Tumor-only variant calling with unmatched normal controls, NAR","volume":"3","author":"Little","year":"2021","journal-title":"Cancer"},{"key":"2024123101253107700_ref24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/bioinformatics\/btv685","article-title":"SomVarIUS: Somatic variant identification from unpaired tissue samples","volume":"32","author":"Smith","year":"2015","journal-title":"Bioinformatics"},{"key":"2024123101253107700_ref25","first-page":"861054","article-title":"Calling somatic SNVs and Indels with Mutect2","author":"Benjamin","year":"2019","journal-title":"bioRxiv"},{"key":"2024123101253107700_ref26","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/jamaoncol.2022.1981","article-title":"Association of High Tumor Mutation Burden in non-small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 expression levels","volume":"8","author":"Ricciuti","year":"2022","journal-title":"JAMA Oncol"},{"key":"2024123101253107700_ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-017-0446-9","article-title":"ISOWN: Accurate somatic mutation identification in the absence of normal tissue controls","volume":"9","author":"Kalatskaya","year":"2017","journal-title":"Genome Med"},{"key":"2024123101253107700_ref28","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41592-023-02043-2","article-title":"Comprehensive benchmarking and guidelines of mosaic variant calling strategies","volume":"20","author":"Ha","year":"2023","journal-title":"Nat Methods"},{"key":"2024123101253107700_ref29","doi-asserted-by":"crossref","first-page":"283ra253","DOI":"10.1126\/scitranslmed.aaa7161","article-title":"Personalized genomic analyses for cancer mutation discovery and interpretation","volume":"7","author":"Jones","year":"2015","journal-title":"Sci Transl Med"},{"key":"2024123101253107700_ref30","doi-asserted-by":"crossref","first-page":"16910","DOI":"10.1073\/pnas.1009843107","article-title":"Allele-specific copy number analysis of tumors","volume":"107","author":"van Loo","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024123101253107700_ref31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmoldx.2017.01.011","article-title":"Guidelines for validation of next-generation sequencing-based oncology panels: A joint consensus recommendation of the Association for Molecular Pathology and College of American pathologists","volume":"19","author":"Jennings","year":"2017","journal-title":"J Mol Diagn"},{"key":"2024123101253107700_ref32","doi-asserted-by":"crossref","first-page":"e0237802","DOI":"10.1371\/journal.pone.0237802","article-title":"Clinical and analytical validation of FoundationOne liquid CDx, a novel 324-gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin","volume":"15","author":"Woodhouse","year":"2020","journal-title":"PloS One"},{"key":"2024123101253107700_ref33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jmoldx.2016.10.007","article-title":"Analytical validation of the next-generation sequencing assay for a Nationwide signal-finding clinical trial: Molecular analysis for therapy choice clinical trial","volume":"19","author":"Lih","year":"2017","journal-title":"J Mol Diagn"},{"key":"2024123101253107700_ref34","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1634\/theoncologist.2019-0244","article-title":"Tumor mutational burden as a predictive biomarker for response to immune checkpoint inhibitors: A review of current evidence","volume":"25","author":"Klempner","year":"2020","journal-title":"Oncologist"},{"key":"2024123101253107700_ref35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/ijms18010107","article-title":"Clinical significance and prognostic relevance of microsatellite instability in sporadic colorectal cancer patients","volume":"18","author":"Copija","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2024123101253107700_ref36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-20-0672","article-title":"Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response","volume":"11","author":"Montesion","year":"2021","journal-title":"Cancer Discov"},{"key":"2024123101253107700_ref37","doi-asserted-by":"crossref","first-page":"e1211","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-specific HLA loss and immune escape in lung cancer evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"2024123101253107700_ref38","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1164\/rccm.202101-0119OC","article-title":"Multiomics analysis reveals distinct Immunogenomic features of lung cancer with ground-glass opacity","volume":"204","author":"Chen","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024123101253107700_ref39","doi-asserted-by":"crossref","first-page":"e003773","DOI":"10.1136\/jitc-2021-003773","article-title":"Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers","volume":"9","author":"Hu","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2024123101253107700_ref40","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1038\/s41467-020-19855-x","article-title":"Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/26\/1\/bbae677\/61294004\/bbae677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/26\/1\/bbae677\/61294004\/bbae677.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T01:27:08Z","timestamp":1735608428000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbae677\/7934567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbae677","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,11,22]]},"article-number":"bbae677"}}